Clinical trial NCT00951262: Intervention Study on Life Review Among Advanced Cancer Patients in Fuzhou, China
Official title: Development and Evaluation of a Life Review Program for Advanced Cancer Patients in Fuzhou, China
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Advanced Cancer
Keywords: life review
quality of life
advanced cancer patients
Lead sponsor: The Hong Kong Polytechnic University
Sponsor class: OTHER
First posted: 2009-08-04
Enrollment: 80
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: This study aims to develop a life review program and test its effectiveness on a sample of patients with advanced cancer patients receiving palliative care at home in Fuzhou.

Detailed description: A life review program is mainly developed based on Erickson's theory, Confucius's teaching on human development, and the empirical findings of the researcher's preliminary study and pre-pilot study. The program covers reviewing a life for advanced cancer patients and formulating a booklet for them. A randomized controlled trial will be adopted for evaluation of this program. Eligible patients will be randomly assigned to the experimental group and the control group. The subjects in the experimental group will receive a life review program for three weeks. The outcome measure is quality of life (QOL), including domains of physical discomfort, food-related concerns, health care concerns, support, negative emotions, sense of alienation, existential distress and value of life. Subjects' QOL will be assessed before commencement of the program (T0) and one day (T1) and three weeks (T2) after the completion of the program for all subjects in two groups. Perceptions of the program will be elicited within three days after the program for subjects in the experimental group.Descriptive statistics will be used to analyze patients' personal information, disease related information, functional performance and QOL of advanced cancer patients. Repeated measures ANOVA will be used to measure QOL differences in between-group, within-group and interaction effects. Content analysis will be used to analyze the qualitative data collected.

Eligibility criteria: Inclusion Criteria:

1. Patients who are newly admitted to the study hospice
2. Patients who are suffering from cancer with metastasis made by a physician
3. Patients who know their diagnosis, prognosis and therapy
4. Patients' functional performance (the score of KPS) at or more than 50%
5. Patients who are adults (≥18 years old)
6. Patients who have no cognitive and verbal communication impairments

Exclusion Criteria:

1. Patients with planned treatments, such as chemotherapy, radiotherapy or surgery
2. Patients with psychiatric disorders
3. Patients who live outside Fuzhou since the following-up home visit services are not extended to those areas

Primary outcomes:
measure: quality of life
timeFrame: three weeks and six weeks
Secondary outcomes:
Other outcomes:
Locations:
city: Fuzhou
country: China
facility: The Fujian Hospice
state: Fujian
Study officials:
affiliation: School of Nursing, The Hong Kong Polytechnic University
name: Enid Kwong, PhD
role: PRINCIPAL_INVESTIGATOR
References: